N
Naoto T. Ueno
Researcher at University of Texas MD Anderson Cancer Center
Publications - 390
Citations - 13778
Naoto T. Ueno is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Breast cancer & Inflammatory breast cancer. The author has an hindex of 59, co-authored 389 publications receiving 11623 citations. Previous affiliations of Naoto T. Ueno include University of Texas Health Science Center at Houston & The Breast Cancer Research Foundation.
Papers
More filters
Journal ArticleDOI
Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early
Shaheenah Dawood,Shaheenah Dawood,Naoto T. Ueno,Vicente Valero,Wendy A. Woodward,Thomas A. Buchholz,Gabriel N. Hortobagyi,Ana M. Gonzalez-Angulo,Massimo Cristofanilli +8 more
TL;DR: In the era of multidisciplinary management and anthracycline-based and taxane-based polychemotherapy regimens, women with IBC continue to have worse survival outcomes compared with those with non-IBC LABC.
Journal ArticleDOI
Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer
Dongwei Zhang,Tiffany A. LaFortune,Savitri Krishnamurthy,Francisco J. Esteva,Massimo Cristofanilli,Ping Liu,Anthony Lucci,Balraj Singh,Mien Chie Hung,Gabriel N. Hortobagyi,Naoto T. Ueno +10 more
TL;DR: The EGFR pathway is involved in tumor growth and metastasis of IBC, and targeting EGFR through the ERK pathway may represent an effective therapeutic approach to suppress tumorigenicity and prevent metastasis in EGFR-expressing IBC.
Journal ArticleDOI
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.
Mario Giuliano,Mario Giuliano,Antonio Giordano,Antonio Giordano,S. Jackson,Ugo De Giorgi,Michal Mego,Michal Mego,Evan N. Cohen,Hui Gao,Simone Anfossi,Beverly Carol Handy,Naoto T. Ueno,Ricardo H. Alvarez,Sabino De Placido,Vicente Valero,Gabriel N. Hortobagyi,James M. Reuben,Massimo Cristofanilli,Massimo Cristofanilli +19 more
TL;DR: The results suggest that baseline CTC counts can be used as an early predictor of metastatic potential in breast cancer patients with limited metastatic dissemination.
Journal ArticleDOI
Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells
Michal Mego,Michal Mego,Ugo De Giorgi,Shahenaah Dawood,Xuemei Wang,Vicente Valero,Eleni Andreopoulou,Beverly Carol Handy,Naoto T. Ueno,James M. Reuben,Massimo Cristofanilli +10 more
TL;DR: It was shown that some important metastatic disease characteristics are predictive of undetectable CTC status in MBC and hormone receptors, number of metastatic sites and lines of therapy were independent prognostic factors for OS in patients without detectable CTC.
Journal ArticleDOI
Future directions of bone-targeted therapy for metastatic breast cancer
TL;DR: The progress and future directions of novel bone-targeted therapies that may reduce or prevent destructive bone metastasis from breast cancer are described.